In emergence from anesthesia, reversal of neuromuscular blockade is best achieved with which agent?

Prepare for the NOVA Clinical Anesthesia Exam. Study with flashcards and multiple choice questions, including detailed explanations and hints. Ace your exam with confidence!

Multiple Choice

In emergence from anesthesia, reversal of neuromuscular blockade is best achieved with which agent?

Explanation:
Reversal of neuromuscular blockade is most effective when you can rapidly and completely remove the blockade, even if it’s deep, without relying on increasing acetylcholine levels. Sugammadex does this by binding the steroidal neuromuscular blockers rocuronium and vecuronium in the plasma, forming a stable complex and freeing the nerves to function normally. This gives a fast, reliable return of muscle strength and, importantly, lowers the risk of residual paralysis that can linger after emergence. In contrast, acetylcholinesterase inhibitors like neostigmine or edrophonium increase acetylcholine to outcompete the NMBA at the nerve junction. They work best when some spontaneous recovery has already occurred and they can cause muscarinic side effects (bradycardia, increased secretions, bronchial constriction) that require an anticholinergic drug to counteract. Glycopyrrolate is an anticholinergic used with these agents to blunt those effects, not to reverse the blockade itself. Because sugammadex can quickly reverse even deep or high-dose rocuronium/vecuronium blockade and avoids the need for antimuscarinic coadministration, it is the preferred option for emergence whenever a steroidal NMBA has been used.

Reversal of neuromuscular blockade is most effective when you can rapidly and completely remove the blockade, even if it’s deep, without relying on increasing acetylcholine levels. Sugammadex does this by binding the steroidal neuromuscular blockers rocuronium and vecuronium in the plasma, forming a stable complex and freeing the nerves to function normally. This gives a fast, reliable return of muscle strength and, importantly, lowers the risk of residual paralysis that can linger after emergence.

In contrast, acetylcholinesterase inhibitors like neostigmine or edrophonium increase acetylcholine to outcompete the NMBA at the nerve junction. They work best when some spontaneous recovery has already occurred and they can cause muscarinic side effects (bradycardia, increased secretions, bronchial constriction) that require an anticholinergic drug to counteract. Glycopyrrolate is an anticholinergic used with these agents to blunt those effects, not to reverse the blockade itself.

Because sugammadex can quickly reverse even deep or high-dose rocuronium/vecuronium blockade and avoids the need for antimuscarinic coadministration, it is the preferred option for emergence whenever a steroidal NMBA has been used.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy